{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:47:21Z","timestamp":1784634441134,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009882","name":"Regione Lombardia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009882","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ricerca Corrente, Istituto Auxologico Italiano"},{"name":"NIH-NIAMS","award":["5R01AR05674502"],"award-info":[{"award-number":["5R01AR05674502"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.jaut.2011.11.009","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T10:22:59Z","timestamp":1324549379000},"page":"J209-J215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Anti-phospholipid induced murine fetal loss: Novel protective effect of a peptide targeting the \u03b22 glycoprotein I phospholipid-binding site. Implications for human fetal loss"],"prefix":"10.1016","volume":"38","author":[{"given":"Yeny","family":"Martinez de la Torre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pregnolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"D\u2019Amelio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Di Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Pasqualini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Nebuloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pojen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pierangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Bassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Ambrogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Orietta","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annunciata","family":"Vecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Locati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier-Luigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2011.11.009_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jaut.2011.11.009_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of the antiphospholipid syndrome (APS): understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat Rev Rheumathol"},{"key":"10.1016\/j.jaut.2011.11.009_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0961203309361351","article-title":"Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view","volume":"19","author":"Meroni","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2011.11.009_bib4","unstructured":"Danza A, Ruiz-Irastorza G, Khamashta M. Antiphospohlipid syndrome in obstetrics. Best Pract Res Clin Obstet Gynaecol; 2011 Nov 10 [Epub ahead of print]."},{"key":"10.1016\/j.jaut.2011.11.009_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12016-007-8055-9","article-title":"Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss","volume":"34","author":"Meroni","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaut.2011.11.009_bib6","series-title":"Hughes\u2019 syndrome","first-page":"362","article-title":"Placental pathology in antiphospholipid syndrome","author":"Park","year":"2006"},{"key":"10.1016\/j.jaut.2011.11.009_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"Holers","year":"2002","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2011.11.009_bib8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4049\/jimmunol.174.1.485","article-title":"TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss","volume":"174","author":"Berman","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2011.11.009_bib9","first-page":"3453","article-title":"Neutrophil activation by the tissue factor\/Factor VIIa\/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome","volume":"118","author":"Redecha","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaut.2011.11.009_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12016-009-8187-1","article-title":"Role of tissue factor in the maternal immunological attack of the embryo in the antiphospholipid syndrome","volume":"39","author":"Girardi","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaut.2011.11.009_bib11","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.molimm.2011.04.011","article-title":"Complement activation in animal and human pregnancies as a model for immunological recognition","volume":"48","author":"Girardi","year":"2011","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaut.2011.11.009_bib12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/molehr\/gal048","article-title":"Impaired expression of endometrial differentiation markers and complement regulatory proteins in patients with recurrent pregnancy loss associated with antiphospholipid syndrome","volume":"12","author":"Francis","year":"2006","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.jaut.2011.11.009_bib13","doi-asserted-by":"crossref","first-page":"167.e1","DOI":"10.1016\/j.ajog.2006.10.879","article-title":"Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies","volume":"196","author":"Shamonki","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaut.2011.11.009_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaut.2007.02.013","article-title":"Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process?","volume":"28","author":"Cavazzana","year":"2007","journal-title":"J\u00a0Autoimmun"},{"issue":"S3","key":"10.1016\/j.jaut.2011.11.009_bib15","first-page":"210","article-title":"Complement involvement in antiphospholipid antibody-mediated placental damage: prospective study in APS pregnant women","volume":"68","author":"Gerosa","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2011.11.009_bib16","first-page":"109","article-title":"Antiphospholipid antibodies reactivity with human decidual cells: an additional mechanism of pregnancy complications in APS and a potential target for innovative therapeutic intervention","volume":"68","author":"Borghi","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2011.11.009_bib17","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1073\/pnas.0607514104","article-title":"Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6","volume":"104","author":"Martinez de la Torre","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jaut.2011.11.009_bib18","first-page":"S404","article-title":"Pregnant naive mice are protected from aPL-induced f\u0153tal loss by the injection of a synthetic peptide (TIFI) mimicking the \u03b22GPI PL-binding site","volume":"58","author":"Martinez de la Torre","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2011.11.009_bib19","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1111\/j.1538-7836.2011.04475.x","article-title":"Evidence for heterogeneity of the obstetric antiphospholipid syndrome: thrombosis can be critical for antiphospholipid-induced pregnancy loss","volume":"9","author":"Poindron","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jaut.2011.11.009_bib20","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1182\/blood-2011-01-333617","article-title":"In\u00a0vivo distribution of \u03b22 glycoprotein I under various pathophysiological conditions [published online ahead of print Jul 26, 2011]","volume":"118","author":"Agostinis","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2011.11.009_bib21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1191\/0961203306lu2315oa","article-title":"A\u00a0peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice","volume":"15","author":"Ostertag","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2011.11.009_bib22","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2005-03-1319","article-title":"Thrombus formation induced by antibodies to \u03b22-glycoprotein I is complement dependent and requires a priming factor","volume":"106","author":"Fischetti","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2011.11.009_bib23","first-page":"102","article-title":"Characterization of IgG monoclonal anti-cardiolipin\/anti\u03b22GP1 antibodies from two patients with the anti-phospholipid syndrome reveals three species of antibodies","volume":"105","author":"Zhu","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaut.2011.11.009_bib24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.10130","article-title":"Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in\u00a0vivo","volume":"46","author":"Gharavi","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2011.11.009_bib25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/ard.2004.021444","article-title":"Pathogenic role of anti-beta 2 glycoprotein I antibodies in antiphospholipid-associated fetal loss: characterisation of beta 2 glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2 glycoprotein I antibodies in\u00a0vitro","volume":"64","author":"Di Simone","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2011.11.009_bib26","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/gb-2003-4-10-r70","article-title":"Identifying biological themes within lists of genes with EASE","volume":"4","author":"Hosack","year":"2003","journal-title":"Genome Biol"},{"key":"10.1016\/j.jaut.2011.11.009_bib27","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/bioinformatics\/bth088","article-title":"GOstat: find statistically overrepresented gene ontologies within a group of genes","volume":"20","author":"Beissbarth","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaut.2011.11.009_bib28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/0961203310395054","article-title":"Obstetric Task Force. Report of the obstetric APS task force: 13th international congress on antiphospholipid antibodies, 13th April 2010","volume":"20","author":"Branch","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2011.11.009_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/BOR.0b013e328344c3f7","article-title":"Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome)","volume":"23","author":"Hoppe","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaut.2011.11.009_bib30","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2011.11.009_bib31","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0002-9378(92)91596-3","article-title":"Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment","volume":"166","author":"Cowchock","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaut.2011.11.009_bib32","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1182\/blood-2011-02-339234","article-title":"First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss","volume":"117","author":"Bramham","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2011.11.009_bib33","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/AOG.0b013e3181deba40","article-title":"Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis","volume":"115","author":"Ziakas","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaut.2011.11.009_bib34","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/rheumatology\/ker139","article-title":"Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study","volume":"50","author":"Ruffatti","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2011.11.009_bib35","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/art.27361","article-title":"Decreased expression of heparin-binding epidermal growth factor-like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation","volume":"62","author":"Di Simone","year":"2010","journal-title":"Arthritis Rheum"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841111001223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841111001223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:07:39Z","timestamp":1760256459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841111001223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":35,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0896841111001223"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2011.11.009","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-phospholipid induced murine fetal loss: Novel protective effect of a peptide targeting the \u03b22 glycoprotein I phospholipid-binding site. Implications for human fetal loss","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2011.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}